Compliance with prospective trial registration guidance remained low in high-impact journals and has implications for primary end point reporting

Twenty-eight percent of trials published in high-impact journals were retrospectively registered including nearly 10% that were registered after primary end point ascertainment could have had taken place. Prospective registration should be prompted and enforced to ensure transparency and accountability in clinical research.